
Loading, please wait...

Loading, please wait...

Clinicians often face complex dilemmas when end-of-life care wishes are contested by family members or appointed surrogates. This scenario becomes particularly challenging when a patient loses capacity. While the primary goal is to respect patient autonomy, surrogate decision-makers may sometimes act against documented or previously stated preferences. Consequently, this conflict creates significant moral distress for the medical team. Therefore, practitioners need a structured ethical approach to navigate these sensitive situations.
When a surrogate disagrees with the care team, the first step involves open communication. Frequently, surrogates experience guilt or emotional burden, which clouds their judgment. Thus, clinicians must facilitate detailed family meetings to clarify the patient’s prior values. In the Indian legal landscape, the Supreme Court has provided specific guidelines for Advance Medical Directives. Similarly, doctors should document every step of the mediation process to ensure legal protection. Furthermore, palliative care specialists can offer valuable insights into managing the patient’s comfort while these disputes are resolved.
Moreover, involve hospital ethics committees early. These committees provide a neutral platform for resolution. However, if the surrogate persists in a decision that clearly contradicts known preferences, legal intervention may be necessary. Additionally, understanding the distinction between life-prolonging treatment and comfort care is essential for all parties involved. As a result, clear communication helps in aligning the care plan with the patient's original intent.
Initially, the doctor should attempt to resolve the conflict through multiple family meetings. If the surrogate's decision contradicts the patient's known preferences, the medical team should consult the institutional ethics committee and review local legal guidelines regarding advance directives.
In India, the Supreme Court recognizes the validity of Advance Medical Directives (Living Wills). If a surrogate acts against such a directive or the patient's best interest, the case may require review by a two-tier medical board or judicial intervention as per the latest 2023 guidelines.
Disclaimer: This content is for informational and educational purposes only. It does not constitute legal or medical advice. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case study exploration of ethical and legal strategies when surrogate decision-makers disagree with a patient's stated hospice care preferences....
5 months ago

A novel oral nanoplatform using Lacticaseibacillus paracasei-derived extracellular vesicles delivers alendronate, reversing glucocorticoid-induced bone loss and restoring gut-immune-bone homeostasis.
Today

A study in JAMIA Open shows lightweight open-source reasoning LLMs achieve up to 95% sensitivity and accelerate evidence synthesis screening by nearly twentyfold, presenting a cost-effective, scalable AI solution for biomedical research and systematic reviews.
Yesterday

A landmark study details how an enterprise pediatric remote patient management model expanded from a single cardiology pilot to 16 diverse specialty programs by combining centralized digital operations with specialty clinical leadership.
Yesterday

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Yesterday

A real-world trial evaluating a near-infrared spectroscopy noninvasive glucose monitoring device in adults with type 2 diabetes demonstrated a combined MAD/MARD of 16.3 across 2,616 paired readings, highlighting its clinical feasibility.
Today